MHRA
MHRA to consult on potential for no-deal Brexit
October 5, 2018Medical Communications EU, MHRA, brexit, uk politics
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …
Drug safety: UK and EU post-Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance
What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
Top Ten most popular articles on Pharmafile.com this week
September 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10
Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …
MHRA loses EMA contracts in wake of Brexit
September 3, 2018Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
Top Ten most popular articles on Pharmafile.com this week
August 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10
There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
MHRA sets out Brexit implementation period plan
August 7, 2018Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period
The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
MHRA bans sodium valproate in the UK following birth defect controversy
April 24, 2018Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …
Top Ten most popular articles on Pharmafile.com this week
April 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical
It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …
Pfizer’s Viagra Connect becomes first erectile dysfunction drug available over-the-counter in UK
November 29, 2017Research and Development, Sales and Marketing MHRA, Pfizer, Viagra Connect, erectile dysfunction, pharma, viagra
Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
Ministers move to clarify drug regulation Post-Brexit
July 4, 2017Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE
Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …
Patients in UK to be given early access to Sanofi’s eczema treatment
March 14, 2017Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi
Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
Brexit could delay key drugs to UK patients, ex-MHRA chairman claims
February 10, 2017Medical Communications, Sales and Marketing Cancer, MHRA, brexit
Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …
Socially vigilant: Does pharmacovigilance need secondary data & social media?
February 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance
As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …
MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme
January 25, 2017Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq
Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
